BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11297763)

  • 21. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
    Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
    Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases.
    Hahn M; Wieland I; Koufaki ON; Görgens H; Sobottka SB; Schackert G; Schackert HK
    Clin Cancer Res; 1999 Sep; 5(9):2431-7. PubMed ID: 10499615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN/MMAC1 mutations in hepatocellular carcinomas.
    Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
    Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
    Tsao H; Goel V; Wu H; Yang G; Haluska FG
    J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
    Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
    J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
    Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
    Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
    Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
    Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
    Aggerholm A; Grønbaek K; Guldberg P; Hokland P
    Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
    Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
    Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.